bio-key international - BKYI

BKYI

Close Chg Chg %
2.71 0.03 0.92%

Open Market

2.74

+0.03 (0.92%)

Volume: 1.75K

Last Updated:

Sep 10, 2026, 10:55 AM EDT

Company Overview: bio-key international - BKYI

BKYI Key Data

Open

$2.70

Day Range

2.70 - 2.77

52 Week Range

2.57 - 19.70

Market Cap

$3.84M

Shares Outstanding

1.44M

Public Float

1.27M

Beta

0.40

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$4.07

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

63.84K

 

BKYI Performance

1 Week
 
-2.49%
 
1 Month
 
-13.84%
 
3 Months
 
-33.82%
 
1 Year
 
-64.47%
 
5 Years
 
-99.51%
 

BKYI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About bio-key international - BKYI

BIO-key International, Inc. engages in the provision of an identity and access management platform. The firm's products include PortalGuard, Admin Panel, Hardware, Identity-Bound Biometrics, and MobileAuth. It offers its services to the education, finance, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Holmdel, NJ.

BKYI At a Glance

BIO-key International, Inc.
101 Crawfords Corner Road
Holmdel, New Jersey 07733
Phone 1-732-359-1100 Revenue 5.94M
Industry Information Technology Services Net Income -7,157,946.00
Sector Technology Services Employees 42
Fiscal Year-end 12 / 2026
View SEC Filings

BKYI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.604
Price to Book Ratio 1.146
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.403
Enterprise Value to Sales 0.268
Total Debt to Enterprise Value 0.442

BKYI Efficiency

Revenue/Employee 141,370.357
Income Per Employee -170,427.286
Receivables Turnover 4.864
Total Asset Turnover 0.702

BKYI Liquidity

Current Ratio 1.466
Quick Ratio 1.346
Cash Ratio 0.87

BKYI Profitability

Gross Margin 76.875
Operating Margin -72.885
Pretax Margin -120.276
Net Margin -120.554
Return on Assets -84.615
Return on Equity -161.236
Return on Total Capital -123.191
Return on Invested Capital -159.174

BKYI Capital Structure

Total Debt to Total Equity 13.778
Total Debt to Total Capital 12.11
Total Debt to Total Assets 8.474
Long-Term Debt to Equity 0.416
Long-Term Debt to Total Capital 0.366
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Bio-key International - BKYI

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
7.02M 7.75M 6.93M 5.94M
Sales Growth
+37.26% +10.46% -10.64% -14.32%
Cost of Goods Sold (COGS) incl D&A
2.44M 6.32M 1.29M 1.37M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
546.01K 590.14K 477.53K 377.15K
Depreciation
199.15K 235.59K 172.55K 109.88K
Amortization of Intangibles
346.87K 354.56K 304.98K 267.27K
COGS Growth
+45.83% +159.21% -79.61% +6.49%
Gross Income
4.58M 1.43M 5.64M 4.56M
Gross Income Growth
+33.10% -68.75% +294.06% -19.07%
Gross Profit Margin
+65.25% +18.46% +81.39% +76.88%
2022 2023 2024 2025 5-year trend
SG&A Expense
12.62M 10.26M 9.65M 8.89M
Research & Development
3.25M 2.39M 2.51M 2.61M
Other SG&A
9.36M 7.86M 7.14M 6.28M
SGA Growth
+50.50% -18.70% -5.91% -7.87%
Other Operating Expense
- - - -
-
Unusual Expense
- 3.43M (396.20K) 2.50M
EBIT after Unusual Expense
(11.47M) (8.43M) (4.01M) (6.83M)
Non Operating Income/Expense
(452.59K) (7.47K) (12.89K) 3.79K
Non-Operating Interest Income
233 11.53K 110 3.79K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
10.46K 218.27K 299.75K 317.63K
Interest Expense Growth
-41.88% +1,986.31% +37.33% +5.96%
Gross Interest Expense
10.46K 218.27K 299.75K 317.63K
Interest Capitalized
- - - -
-
Pretax Income
(11.93M) (8.66M) (4.32M) (7.14M)
Pretax Income Growth
-135.51% +27.45% +50.05% -65.17%
Pretax Margin
-169.94% -111.62% -62.39% -120.28%
Income Tax
(20.43K) (134.01K) (23.00K) 16.50K
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - 40.99K
-
Income Tax - Deferred - Domestic
- - - (434)
-
Income Tax - Deferred - Foreign
(20.00K) (175.00K) (23.00K) 16.50K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(11.91M) (8.52M) (4.30M) (7.16M)
Minority Interest Expense
- - - -
-
Net Income
(11.91M) (8.52M) (4.30M) (7.16M)
Net Income Growth
-135.10% +28.45% +49.53% -66.44%
Net Margin Growth
-169.65% -109.89% -62.06% -120.55%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(11.91M) (8.52M) (4.30M) (7.16M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(11.91M) (8.52M) (4.30M) (7.16M)
EPS (Basic)
-264.6396 -152.1002 -20.8783 -10.7676
EPS (Basic) Growth
-126.14% +42.53% +86.27% +48.43%
Basic Shares Outstanding
45.00K 56.03K 205.99K 664.77K
EPS (Diluted)
-264.6396 -152.1002 -20.8783 -10.7676
EPS (Diluted) Growth
-126.14% +42.53% +86.27% +48.43%
Diluted Shares Outstanding
45.00K 56.03K 205.99K 664.77K
EBITDA
(7.49M) (8.24M) (3.53M) (3.95M)
EBITDA Growth
-69.17% -9.96% +57.10% -11.80%
EBITDA Margin
-106.70% -106.21% -50.99% -66.53%

Snapshot

Average Recommendation BUY Average Target Price 20.00
Number of Ratings 1 Current Quarters Estimate -0.35
FY Report Date 09 / 2026 Current Year's Estimate -1.62
Last Quarter’s Earnings -0.56 Median PE on CY Estimate N/A
Year Ago Earnings -6.90 Next Fiscal Year Estimate 0.22
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate -0.35 -0.24 -1.62 0.22
High Estimates -0.35 -0.24 -1.62 0.22
Low Estimate -0.35 -0.24 -1.62 0.22
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Bio-Key International in the News